✦ LIBER ✦

Non-peptide fibrinogen receptor antagonists. 41. The synthesis of [3H]L-756,568

✍ Scribed by Terence G. Hamill; John H. Hutchinson; Karen M. Brashear; George D. Hartman

Publisher: John Wiley and Sons
Year: 1999
Tongue: French
Weight: 228 KB
Volume: 42
Category: Article
ISSN: 0022-2135
DOI: 10.1002/(sici)1099-1344(199906)42:6<605::aid-jlcr222>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-peptide fibrinogen receptor antagoni

Non-peptide fibrinogen receptor antagonists. 21. The synthesis of [3H]L-738,167

✍ Terence G. Hamill; Ben C. Askew; George D. Hartman; David A. Claremon; Charles J 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 1 views

Non-peptide fibrinogen receptor antagoni

Non-peptide fibrinogen receptor antagonists. 31. The synthesis of [3H]L-767,685 and [3H]L-767,679

✍ Terence G. Hamill; John H. Hutchinson; George D. Hartman; H. Donald Burns 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 246 KB 👁 1 views

The synthesis of [3H]L-734,217, an orall

The synthesis of [3H]L-734,217, an orally active fibrinogen receptor antagonist

✍ T.G. Hamill; M.E. Duggan; G.D. Hartman; W.F. Hoffman; J.J. Perkins; H.D. Burns 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 407 KB 👁 1 views

The synthesis of [3H]L-734,217, lb, an orally active fibrinogen receptor antagonist, is described. The conversion of 3-amino crotonate 6 to [3H]L-734,217 was carried out via a two step sequence of catalytic tritiation followed by basic hydrolysis. Deuterium model reactions showed that the reduction

ChemInform Abstract: Investigation of th

ChemInform Abstract: Investigation of the 4-O-Alkylamine Substituent of Non-peptide Quinolone GnRH Receptor Antagonists.

✍ Robert J. DeVita; Mark T. Goulet; Matthew J. Wyvratt; Michael H. Fisher; Jane-L. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB

ChemInform Abstract: Highly Potent and O

ChemInform Abstract: Highly Potent and Orally Active Non-peptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 4′-[(4,4-Difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-yl )carbonyl]-2-phenylbenzanilide Derivatives.

✍ Yoshiaki Shimada; Nobuaki Taniguchi; Akira Matsuhisa; Kenichiro Sakamoto; Takeyu 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 44 KB 👁 2 views